Christopher Gibson, CEO: Recursion Pharmaceuticals RXRX Sell · Filed 24/03/08

Trade details

Type: Insider sale
Amount: $430,743.34
Shares · price: 36,319 sh · $11.86 a share
Held after: 1,108,524 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Christopher GibsonCEO
Trade date: 24/03/06
Filed: 24/03/08
Days to filing: 2 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/02/05~24/04/05

Christopher Gibson's recent trades

Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$262K
77,290 sh
$262K
Filed 08/21
Traded 08/21
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$255K
75,000 sh
$255K
Filed 08/20
Traded 08/20
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$327.5K
100,000 sh
$327.5K
Filed 08/19
Traded 08/19
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$80.4K
26,806 sh
$80.4K
Filed 08/18
Traded 08/18
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$331K
100,000 sh
$331K
Filed 08/13
Traded 08/13

Christopher Gibson, CEO — sold $430.7K of Recursion Pharmaceuticals RXRX · 3.2% of holdings | Whalegun